🇺🇸 FDA
Patent

US 6689338

Bioconjugates of nanoparticles as radiopharmaceuticals

expired A61KA61K47/6923A61K51/1244

Quick answer

US patent 6689338 (Bioconjugates of nanoparticles as radiopharmaceuticals) held by The Board of Regents for Oklahoma State University expires Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents for Oklahoma State University
Grant date
Tue Feb 10 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K47/6923, A61K51/1244, A61P, A61P35/00